Related Experiment Video
Updated: Sep 11, 2025

06:03
Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
6.7K
AI-Based Ultrasound Nomogram for Differentiating Invasive from Non-Invasive Breast Cancer Masses
Meng-Yuan Tsai1,2,3,4, Zi-Han Yu1,5, Chen-Pin Chou1,6
1Department of Radiology, Kaohsiung Veterans General Hospital, Kaohsiung 813414, Taiwan.
Cancers
|August 14, 2025
Summary
This study developed an AI-powered nomogram using ultrasound features to accurately differentiate ductal carcinoma in situ (DCIS) from invasive ductal carcinoma (IDC), improving non-invasive breast cancer diagnosis.
Area of Science:
- Radiology and Medical Imaging
- Oncology
- Artificial Intelligence in Medicine
Background:
- Distinguishing ductal carcinoma in situ (DCIS) from invasive ductal carcinoma (IDC) is crucial for effective breast cancer treatment.
- Ultrasound is a primary imaging modality, but differentiating these lesions can be challenging.
- AI-driven analysis of imaging features offers potential for improved diagnostic accuracy.
Purpose of the Study:
- To develop and validate a predictive nomogram for differentiating mass-type DCIS from IDC using AI-based BI-RADS lexicons and lesion-to-nipple distance (LND) on ultrasound.
- To assess the nomogram's performance in terms of discrimination and calibration.
Main Methods:
- A retrospective analysis of 175 pathologically confirmed malignant breast lesions (26 DCIS, 149 IDC) from 170 women.
- Integration of AI-derived BI-RADS features (S-Detect) and ultrasound LND measurements.
- Development of a logistic regression-based nomogram, with performance evaluated using ROC curves and calibration plots.
Main Results:
- Smaller lesion size, irregular shape, LND ≤ 3 cm, and non-hypoechoic echogenicity were independent predictors of DCIS.
- The AI-based nomogram demonstrated strong discriminative power (AUC training: 0.851, AUC validation: 0.842).
- Excellent calibration was observed, with non-significant Hosmer-Lemeshow tests and low mean absolute errors.
Conclusions:
- The developed AI-based nomogram is a reliable tool for non-invasively distinguishing mass-type DCIS from IDC.
- This predictive model can enhance preoperative planning and improve diagnostic accuracy in breast cancer.
- AI integration with ultrasound features shows promise for advancing breast cancer diagnostics.

